Dr. Petri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1830 E Monument St Ste 7500
Baltimore, MD 21287Phone+1 410-944-9114Fax+1 410-614-0498
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1983 - 1984
- Massachusetts General HospitalResidency, Internal Medicine, 1980 - 1983
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- CA State Medical License 1983 - Present
- FL State Medical License 2020 - Present
- MD State Medical License 1986 - 2025
- NC State Medical License 2020 - 2022
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Safety of Estrogens in Lupus: Hormone Replacement Therapy Start of enrollment: 1996 Apr 01
- Safety of Estrogens in Lupus: Birth Control Pills Start of enrollment: 1997 Jun 01
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide Start of enrollment: 2000 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsStratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene ExpressionDaniel Toro-Domínguez, Jordi Martorell-Marugán, Daniel Goldman, Michelle Petri, Pedro Carmona-Sáez
Arthritis & Rheumatology. 2018-12-01 - 3109 citationsDerivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.Michelle Petri, Ana Maria Orbai, Graciela S. Alarcón, Caroline Gordon, Joan T. Merrill
Arthritis and Rheumatism. 2012-08-01 - 85 citationsCardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.Michael D. Lockshin, Felicia Tenedios, Michelle Petri, G McCarty, Ricardo Forastiero
Lupus. 2003-01-01
Journal Articles
- Psychosis in Systemic Lupus ErythematosusAnca Askanase, Kenneth C Kalunian, M A Dooley, Meggan Mackay, Ellen M Ginzler, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Joan T Merrill, Michelle Petri, Diane L K..., Arthritis & Rheumatology
- Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology
- Reply to: Is Low Disease Activity Good Enough as a Target in SystemicMichelle Petri, MD, Arthritis & Rheumatology
- Join now to see all
Press Mentions
- Making Sense of the Connection Between Vaccines and Lupus FlaresAugust 8th, 2024
- CAR T-cell Therapy May Be a ‘Miracle,’ but It Is Too Soon to Say ‘Cure’July 22nd, 2024
- Study: Diminished COVID Vaccine Response in LupusJanuary 30th, 2023
- Join now to see all
Grant Support
- Hopkins Lupus CohortNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2012
- Revision Of ACR Classification Criteria For Systemic Lupus ErythematosusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007
- Cognitive Function In Systemic Lupus ErythematosusNational Center For Research Resources2007
- Brain Connections: Add-On Study Of Serial Brain Mris Every SIX MonthsNational Center For Research Resources2007
- Systemic Lupus Erythematosus (SLE)National Center For Research Resources2005–2007
- Prospective Lupus Cohort Study Of Disease Activity And Predictors Of MorbidityNational Center For Research Resources2004–2007
- Lupus Atherosclerosis Prevention Study (LAPS)National Center For Research Resources2004–2007
- Lupus Atherosclerosis Prevention Study (Laps)Par }National Center For Research Resources2006
- Brain Conections: Add-On Study Of Serial Brain Mris Every SIX MonthsNational Center For Research Resources2006
- Lupus Atherosclerosis Prevention Study (LAPS) SupplementNational Center For Research Resources2004–2006
- Lupus CohortNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2006
- Brain ConnectionsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2006
- Revision Of ACR Classification Criteria For SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005
- Program Project In The Genetics Of SLENational Center For Research Resources2004–2005
- Revision Of ACR Classification Criteria For SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
- Phase II Trial Of Idec 131 In Patients With Active SLENational Center For Research Resources2000–2002
- Oral Contraceptive And Hormone Replacement In SLENational Center For Research Resources2000–2002
- Genetic Risk Profile In Longitudinal SLE CohortsNational Center For Research Resources1999–2002
- Specialized Center Of Research--Systemic Lupus ErythrmatosusNational Center For Research Resources1998–2002
- Prospective Lupus Cohort Study Of Disease Activity/Predictors/Morbidity/HealthNational Center For Research Resources1998–2002
- Oral Contraceptive And Hormone Replacement In Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
- Multicenter Trial Of Repeated Dose Of LJP 394 In Patients With SLENational Center For Research Resources1998–2002
- Gl701 In Females With Active Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
- Detection Of Atherosclerosis In Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
- Autoantibody Diversification In SLE FlaresNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2001
- Rand. Clinical Trial Of High Dose Immunoblative TheraNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2000
- Phase IIA Evaluate Effect Of DMP 777 Upon Joint Manifestation In SLENational Center For Research Resources1999
- Trial Of B Vitamin Supplementation To Reduce HomocysteineNational Center For Research Resources1997–1999
- Hopkins Lupus CohortNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996
- Lupus Cohort Thrombotic Events &Coronary Artery DiseaseNational Heart, Lung, And Blood Institute1994–1995
- Lupus Cohort-Thrombotic Events &Coronary Artery DiseaseNational Heart, Lung, And Blood Institute1991–1993
Professional Memberships
- Fellow
Other Languages
- French
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michelle-petri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: